A methodological review of meta-analyses of the effectiveness of clinical psychology treatments by Rubio-Aparicio, María et al.
                          Rubio-Aparicio, M., Marín-Martínez, F., Sánchez-Meca, J., & López-López,
J. A. (2018). A methodological review of meta-analyses of the effectiveness
of clinical psychology treatments. Behavior Research Methods, 50(5), 2057-
2073. https://doi.org/10.3758/s13428-017-0973-8
Peer reviewed version
Link to published version (if available):
10.3758/s13428-017-0973-8
Link to publication record in Explore Bristol Research
PDF-document
This is the author accepted manuscript (AAM). The final published version (version of record) is available online
via Springer at https://link.springer.com/article/10.3758%2Fs13428-017-0973-8 . Please refer to any applicable
terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
1 
 
 
A methodological review of meta-analyses about the effectiveness of clinical 
psychology treatments 
 
Abstract 
This paper presents a methodological review of 54 meta-analyses about the 
effectiveness of clinical psychological treatments, using standardized mean differences 
as the effect size index. We statistically analysed the distribution of the number of 
studies of the meta-analyses, the distribution of the sample sizes in the studies of each 
meta-analysis, the distribution of the effect sizes in each of the meta-analyses, the 
distribution of the between-studies variance values, and the Pearson correlations 
between effect size and sample size in each meta-analysis. The results were presented as 
a function of the type of standardized mean difference: posttest standardized mean 
difference, standardized mean change from pretest to posttest, and standardized mean 
change difference between groups. These findings will help to design future Monte 
Carlo and theoretical studies on the performance of the meta-analytic procedures, based 
on the manipulation of realistic model assumptions and parameters in the meta-
analyses. Furthermore, the analysis of the distribution of the mean effect sizes through 
the meta-analyses provides a specific guide for the interpretation of the clinical 
significance of the different types of standardized mean differences, in the field of the 
evaluation of clinical psychology interventions.      
 
Keywords: meta-analysis; standardized mean difference; clinical significance; Monte 
Carlo studies 
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A methodological review of meta-analyses about the effectiveness of clinical 
psychology treatments 
 
1. Introduction 
 
 Meta-analysis is a form of quantitative systematic review, where the results of a 
series of empirical studies on the same research topic are statistically summarized. 
When the individual studies report results in different scales (e.g., depression symptoms 
measured with different instruments), standardized effect size indices are often used to 
express results across studies in a common metric. The standardized mean difference is 
one of the most used effect size indices, in studies where two or more groups are 
compared on a continuous outcome (Borenstein, Hedges, Higgins, & Rothstein, 2009; 
Cooper, Hedges, & Valentine, 2009).  
 
 The three main statistical objectives in a meta-analysis are to estimate the mean 
effect size through the primary studies, to assess the heterogeneity of the effect size 
estimates around the mean effect size, and to search for moderators that can explain part 
of the heterogeneity among the individual effect size estimates. In the behavioural, 
social, educational and healthcare sciences, these moderators are the differential 
characteristics of the studies, such as the type of design, characteristics of the participant 
samples, or types of interventions (Hedges & Olkin, 1985; Rosenthal, 1991; Sánchez-
Meca & Marín-Martínez, 2010). 
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 There are two main statistical models to carry out a meta-analysis: the fixed-
effect and the random-effects models. Under the fixed-effect model, it is assumed that 
all studies in the meta-analysis estimate a common population effect size, the only 
source of variability among the effect sizes being the sampling error due to the random 
selection of participants in each study (Konstantopoulos & Hedges, 2009). Conversely, 
in the random-effects model, it is assumed that each study in the meta-analysis 
estimates a different population effect size, and that studies are randomly selected of a 
population of studies, assuming that the corresponding population effect sizes are 
normally distributed. As a consequence, in the random-effects model, the effect sizes 
present two sources of variability: between-studies variability and within-study 
variability. Further, an additional assumption of the random-effects model is the 
independence between the sample sizes and the population effect sizes in the primary 
studies of the meta-analysis (Biggerstaff & Tweedie, 1997; Raudenbush, 2009).  
 
 Nowadays, there is a broad consensus that the random-effects model is more 
realistic than the fixed-effect model, due to the methodological and substantive 
differences that are typically found among the studies combined in a meta-analysis 
(Borenstein, Hedges, Higgins, & Rothstein, 2010; Hedges & Vevea, 1998; National 
Research Council, 1992; Raudenbush, 1994, 2009). As a consequence, in this paper we 
will focus on the methodological characteristics of random-effects model meta-analyses.     
 
 The empirical analysis of the methodological characteristics of real meta-
analyses in a specific area of study is useful, as it helps to portrait the “typical” meta-
analytic review that is conducted in a research field (e.g., number of studies, sample size 
distribution in the primary studies, and effect size distribution). Furthermore, a 
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methodological review of meta-analyses allows assessing the degree of compliance with 
model assumptions, such as normal distribution of the effect sizes and independence 
between the sample sizes and effect sizes.  
 
The aim of the present study was to explore the methodological characteristics 
of 54 meta-analyses published in high standard journals, which examined the 
effectiveness of clinical psychological interventions using standardized mean 
differences as the effect size index. This enabled us to provide a guide for the 
interpretation and characterization of the meta-analyses in the context of clinical 
psychology.     
 
 Similar to our study, Levine, Asada, and Carpenter (2009) explored the 
characteristics of 51 published meta-analyses on topics relevant to communication 
researchers (e.g., persuasion and interpersonal communication, language intensity 
effects, or viewing presidential debates). Interestingly, this study found a negative 
correlation between effect size and sample size for most of the meta-analyses revised, 
which may be caused by publication bias.  
 
 Another review of meta-analyses was conducted by Engels, Schmid, Terrin, 
Olkin, and Lau (2000). These authors revised 125 published meta-analyses in the field 
of clinical medicine. They compared the performance of two effect size indices, odds 
ratio and risk difference, usually applied in studies with binary outcomes. Both indices 
yielded the same conclusion when testing the statistical significance of the mean effect 
size within the same meta-analysis. However, risk differences led to larger 
heterogeneity than odds ratios. 
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 Schmidt, Oh, and Hayes (2009) selected 68 meta-analyses where a fixed-effect 
model was assumed, and reanalyzed their findings applying the more realistic random-
effects model. These meta-analyses focused on gender differences and the relations 
between personality and aggressive behaviour. The fixed-effect confidence intervals 
around mean effect sizes showed an overstated and unrealistic precision as compared to 
the wider random-effects confidence intervals. 
 
 Last, Lipsey and Wilson (1993) reported an extensive review of meta-analyses 
about the efficacy of psychological and educational treatment. Some of the analyzed 
characteristics were the magnitude of the effects, samples sizes of the primary studies, 
and methodological quality of the meta-analyses. The main purpose of this study was to 
show the ability of meta-analysis to rigorously assess the degree of effectiveness of the 
treatments.   
 
 The current study focuses on the methodological characteristics of the meta-
analyses about the effectiveness of treatments in the field of Clinical Psychology, with 
the standardized mean difference as the effect size index. Some of these methodological 
characteristics were: the type of standardized mean difference (between-groups or 
within-groups), the distribution of the number of studies of the meta-analyses, the 
distribution of the sample sizes in the studies of each meta-analysis, the distribution of 
the effect sizes in each of the meta-analyses, the distribution of the between-studies 
variance values, and the Pearson correlations between effect size and sample size in 
each meta-analysis.  
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 With this methodological review of meta-analyses we intend to offer a guide for 
the design of future research studies about the performance of the meta-analytic 
procedures (e.g. Monte Carlo or theoretical studies), based on the manipulation of 
realistic assumptions and parameters in the meta-analyses. Furthermore, the analysis of 
the distribution of the average effect sizes through the meta-analyses will provide a 
guide for the interpretation of the clinical significance of the different types of 
standardized mean differences, in the field of the effectiveness of the Clinical 
Psychology treatments. In addition, our results will offer realistic estimates of the effect 
size in this context, which is valuable information for researchers aiming to determine 
the optimal sample size when planning their investigations.  
 
Types of standardized mean differences 
 
If all of the studies included in the meta-analysis report a continuous outcome in 
the same metric, raw mean differences can be used as the effect size index. However, 
this is seldom the case in behavioural and social sciences, where different instruments to 
measure the same construct are usually considered across studies. This is why 
standardized mean differences are widely used in meta-analyses conducted in these 
fields.  
 There are different types of standardized mean differences that suit different 
study designs. In a two-group design (usually experimental vs. control) with a 
continuous outcome, the most usual formula to estimate the population effect size is 
(Hedges & Olkin, 1985):  
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where d is an approximately unbiased estimator of the corresponding parameter, 1y  and  
2y are the means of the two groups in the outcome, n1 and n2 are the sample sizes, and 
Sˆ  is an estimator of the pooled within-group standard deviation given by:  
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1S and 
2
2S  being the unbiased variances of the two groups.  
 
 Hedges and OIkin (1985) also derived the formula of the variance of the d index, 
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 In a repeated measures design, where continuous pretest and posttest measures 
are registered for a sample of subjects (e.g. before and after the intervention), Becker 
(1988) proposed the standardized mean change, based on the difference between the 
pretest and posttest means divided by a standard deviation. Depending on the value of 
the estimated standard deviation in the denominator, there are two proposed d indices 
that we will denote by dc1 and dc2, respectively.   
 
 In a sample with n subjects, prey  and  posy  being the means in the pretest and 
posttest, respectively, dc1 is defined by (Gibbons, Hedeker, & Davis, 1993):  
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where dc1 is an approximately unbiased estimator of the corresponding parameter, and  
Sc is the standard deviation of the change scores from pretest to posttest. The variance of 
dc1 is given by (Morris & DeShon, 2002):  
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 The dc2 index is given by (Becker, 1988; Morris, 2000; Morris & DeShon, 
2002):  
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where Spre is the standard deviation of the pretest scores, that is not influenced by the 
effects of the intervention. Morris (2000) derived the formula for estimating the 
variance of dc2: 
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where r is the Pearson correlation between the pretest and posttest scores.  
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 Note that, in studies with a two independent group design with continuous 
pretest and posttest measures, the most widely used effect size index is the standardized 
mean difference, d, as defined in equation (1), and computed on the posttest scores. 
However, this index is only appropriate when there is random assignment of the 
subjects to the groups and equivalent pretest scores in both groups can be assumed. 
Furthermore, a disadvantage of computing the d index only on the posttest scores is that 
the valuable information of the pretest scores is ignored.  
 
 Becker (1988), Morris and DeSohn (2002), and Morris (2008) proposed three 
effect size indices based on the difference between the standardized mean change in the 
experimental and control groups, that we will denominate dg1, dg2, and dg3. These 
indices, unlike the standardized mean difference computed only on the posttest scores, 
take into account the information in both the pretest and posttest scores of the 
experimental and control groups.    
 
 The dg1 index is given by:  
 
dg1 = dc1,E  − dc1,C ,                                                                                                           (8) 
 
where dc1,E and dc1,C are the standardized mean change defined in Equation (4), for the 
experimental and control groups, respectively. The variance of the dg1 can be estimated 
by:  
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2
,1
ˆ
Ecd
 and 2
,1
ˆ
Ccd
  being the estimated variances of the dc1 indices computed by Equation 
(5) applied on the experimental and control groups, respectively.  
 
 An alternative index to dg1 is dg2, computed as the difference between the 
standardized mean change defined in Equation (6) for the experimental and control 
groups: 
 
dg2 = dc2,E  − dc2,C .                                                                                                        (10) 
 
 The estimated variance of the dg2 index is given by: 
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where 2
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Ecd
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 are the estimated variances of the dc2 indices computed by 
Equation (7) for the experimental and control groups, respectively.  
 
 Assuming the homogeneity of the pretest standard deviations in the experimental 
and control groups, the dg3 index is given by:  
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where nE and nC are the sample sizes of the experimental and control groups, Eprey , and 
Eposy ,  are the means of the experimental group in the pretest and posttest, Cprey ,  and 
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Cposy ,  are the means of the control group in the pretest and posttest, and preS  is given 
by:  
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2
,EpreS and 
2
,CpreS being the variances of the experimental and control groups in the 
pretest.  
 
 Finally, the estimated variance of the dg3 index is given by:  
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where r is the mean of the Pearson correlations between the pretest and posttests scores 
in the experimental and control groups.  
 
2. Methodology 
 
Search procedure and selection criteria of the meta-analyses  
 
 Data for the present study were extracted from a sample of 50 published meta-
analyses about the effectiveness of psychological treatments and interventions. The 
meta-analyses were obtained from journals with impact factor located in the first 
quartile of 2011 Journal Citation Reports in the clinical psychology field (Clinical 
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Psychology Review, Psychological Medicine, Journal of Consulting and Clinical 
Psychology, Depression and Anxiety, Health Psychology, Neuropsychology, Behaviour 
Research and Therapy, and Journal of Substance Abuse Treatment). The search was 
conducted in Google Scholar and limited to meta-analyses published between 2000 and 
2012 with the key words “meta-analysis” OR “systematic review” in the tittle.   
 
 Firstly, reading the title and abstract of each reference allowed us to preselect the 
meta-analyses about the effectiveness of psychological programs, treatments and 
interventions about psychological, educational and psychosocial disorders. To be 
included in or study, meta-analyses had to comply with several selection criteria. First, 
we only included meta-analyses using an effect size index from the d family: posttest 
standardized mean difference (Equation 1), standardized mean change (Equations 4, or 
6), and standardized mean change difference (Equations 8, 10, or 12). Further, meta-
analyses should report the individual effect sizes and sample sizes for the primary 
studies. In order to ensure that the selected meta-analyses had sufficient data to provide 
valid results, they had to include seven or more studies, with sample sizes of at least 
five subjects per group. 
 
 A total of 206 published meta-analyses were revised of which 50 were finally 
included in the study. The included studies are marked with an asterisk in the references 
section. Some meta-analyses used two different effect sizes of the d family (Hesser, 
Weise, Westin, & Andersson, 2011; Nestoriuc, Rief, & Martin, 2008; Sockol, Epperson, 
& Barber, 2011; Virués-Ortega, 2010). In those cases, our decision was to consider 
them as independent meta-analyses. Thus, a total of 54 independent meta-analyses, or 
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analysis units, took part in the present study. These meta-analyses summarized the 
results of 1,285 individual studies.  
 
Data extraction 
 
 A database was created in SPSS, where the effects sizes and sample sizes of the 
individual studies were coded for each meta-analysis. For meta-analyses including 
several outcomes, we selected the most relevant clinical outcome taking into account 
the principal aim of the meta-analysis. The type of design in which the computation of 
the effect size was based, and the type of d index were also recorded. Designs were 
classified as between-groups and within-groups, and type of d was coded as posttest 
standardized mean difference (d in Equation 1), standardized mean change (dc1 or dc2, in 
Equations 4 or 6, respectively), and standardized mean change difference (dg1, dg2, or 
dg3, in Equations  8, 10 or 12, respectively). For each d value, its variance was estimated 
with the Equations (3), (5), (7), (9), (11) or (14), depending on the type of d.  
 
 Data from each meta-analysis were doubly coded by the first two authors of this 
paper, with agreement percentages ranging between 94.44% and 100%. Inconsistencies 
between the coders were solved by consensus.     
  
Meta-analytic calculations 
 
 Several computations were carried out using each meta-analytic database. The 
weighted average effect size was estimated using the following expression:  
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where iT   refers to any d family effect size index, and iwˆ  is the estimated weighting 
factor computed through )ˆˆ/(1ˆ 22 DLiiw   . The within-study variance of each 
individual study, 2ˆ i , was estimated using the formula corresponding to the type of d 
index (see Equations 3, 5, 7, 9, 11, and  14).  The between-studies variance, 2ˆDL , was 
calculated through the procedure of DerSimonian and Laird (1986), the most commonly 
used in practice. In this procedure, the between-studies variance estimator is derived 
from the moment method 
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where k is the number of studies of the meta-analysis, and Q is a statistic to test the 
heterogeneity of the effect sizes, described by Cochran (1954), and obtained by 
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with *ˆ iw  being the estimated weights assuming a fixed-effect model, 
2* ˆ/1ˆ iiw  , and 
*T  the mean effect size also assuming a fixed-effect model, that is, applying Equation 
(15), but using *ˆ iw  as weighting factor; and c is given by 
 
15 
 
 


 
i
i
i
i
i
i
w
w
wc
*
2*
*
ˆ
ˆ
ˆ .                                                                                             (18)                                                               
The mean effect size (Equation 15) was always computed with DL estimator. 
Restricted Maximum Likelihood (REML) and Paule and Mandel (PM) estimators of   
2ˆ  were also applied in order to know the distributions of the between-studies 
variances. Next, we present formulas for these estimators.  
The Restricted Maximum Likelihood estimator is obtained iteratively from 
(Sánchez-Meca & Marín-Martínez, 2008; Viechtbauer, 2005) 
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where iwˆ  are the estimated weighting factor, iT  refers to any d family effect size index,  
2ˆ
i  is the within-study variance of each individual study, and T is defined in Equation 
15. When 2ˆREML < 0, it is truncated to zero.  
The final estimator was also an iterative method proposed by Paule and Mandel 
(1982). Applying this estimator, the between-studies variance is given by 
 
                                                                       (20) 
 
where iwˆ  are the estimated weights, iT  is any of d family effect size, T  is 
defined in Equation 15, and k is the number of studies.  
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 To test for true heterogeneity among the population effect sizes, we calculated 
the Q-statistic defined in Equation (17) for each meta-analysis. Under the hypothesis of 
homogeneity among the effect sizes, the Q statistic follows a chi-square distribution 
with k - 1 degrees of freedom.  
 
 The Q-statistic does not inform researchers of the extent of true heterogeneity, 
only of its statistical significance. Furthermore, the Q test has poor power to detect true 
heterogeneity among the effect sizes when the meta-analysis includes a small number of 
studies (k < 30, Sánchez-Meca & Marín-Martínez, 1997). In order to overcome the 
shortcomings of the Q test, Higgins and Thompson (2002; Higgins, Thompson, Deeks, 
& Altman, 2003) proposed the I2 index for assessing the magnitude of heterogeneity 
exhibited by the effect sizes. For each meta-analysis the I2 index was computed through 
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 The I2 index was interpreted as the percentage of the total variability in a set of 
effect sizes due to true heterogeneity, that is, to between-studies variability. 
Indicatively, I2 rates around 25%, 50% and 75% can be interpreted as reflecting low, 
medium and high heterogeneity, respectively (Huedo-Medina, Sánchez-Meca, Marín-
Martínez, & Botella, 2006).                                                                                                  
 
Data analysis  
 
 The statistical analyses were carried out in R. Specifically, the meta-analytic 
calculations were programmed with the metafor package (Viechtbauer, 2010), using the 
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individual effect sizes and sample sizes coded for each meta-analysis as inputs. For 
repeated measures data, the correlation between pre- and post- assessment was required 
for computation of the variance of dc2 (Equation 7), dg2 (Equation 11), and dg3 (Equation 
14) indices. Following Rosenthal’s (1991) criterion, it was set at r = 0.7, as a 
representative value of the expected correlation in this context.   
 
 The normality assumption for the effect size distribution in each meta-analysis 
was assessed through the Shapiro-Wilk test for small samples, and computing the 
skewness and kurtosis of the distribution. Furthermore, the median, skewness and 
kurtosis were also computed for the sample size distribution in each meta-analysis. 
Descriptive analyses (minimum, maximum, mean, and quartiles) were carried out on the 
next indices through the meta-analyses: number of studies; mean effect size (Equation 
15); p-value of the Shapiro-Wilk test; skewness and kurtosis of the d values; median, 
skewness and kurtosis of the sample sizes distribution; Pearson correlation between 
effect sizes and sample sizes; p-value of the heterogeneity Q statistic (Equation 17); I2 
index (Equation 21); and 2ˆ index (Equations 16, 19 and 20). These analyses were 
performed separately for meta-analyses using the posttest standardized mean difference, 
the standardized mean change, and the standardized mean change difference. 
The R code and 54 meta-analytic databases are available in the Open Science 
Framework (https://osf.io/yd52u/).  
 
3. Results 
 
Characteristics of the meta-analyses  
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 A total of 54 meta-analyses were included in this study, of which 41 used the 
posttest standardized mean difference (between-groups design), 11 used the 
standardized mean change (within-groups design) and 2 used the standardized mean 
change difference (between-groups design). The database with the 54 meta-analyses is 
presented in Appendix 1. The type of d family effect size index, the equation applied to 
estimate the variance of each individual effect size, and some meta-analytic calculations 
were registered for each meta-analysis: number of studies, mean effect size, p-value 
associated to the Q statistic, I2 , and 2ˆDL , 
2ˆ
REML  and 
2ˆ
PM values. We performed these 
calculations using the values of the effect sizes and sample sizes from each meta-
analysis.  
 
 The values of the d indices reported by the authors of the meta-analyses were 
computed as in Equations (1), (4), (6), (8), (10), and (12); or with some slight variations 
of these Equations. Specifically, in some meta-analyses, the dc2  index (Equation 6) was 
computed using pooled standard deviations from pretest and posttest data, instead of the 
standard deviations in the pretest (meta-analyses in Casement & Swanson, 2012; 
Driessen et al., 2010; Hansen et al., 2012; and Williams, Hadjistavropoulos, & Sharpe, 
2006). And in the meta-analysis of Aderka, Nickerson, Bøe, and Hofmann (2001), the 
dg3 index (Equations 12, and 13) was computed using the variances of the change 
scores, instead of the variances in the pretest.      
  
Some meta-analyses included more than one type of d index and, consequently, 
the 50 published meta-analyses were disaggregated in 54 independent meta-analyses. 
For instance, as can be seen in Appendix 1, the meta-analysis in Hesser et al. (2011) 
was disaggregated in two meta-analyses, since the standardized mean difference was 
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used to compare the treatment and control groups at posttest, and the standardized mean 
change was used to evaluate the differences from pretest to posttest for some treatment 
groups.  
 
 Next, the distributions of the number of studies, effect sizes, sample sizes in the 
primary studies, correlations between effect sizes and sample sizes, and heterogeneity 
indices of the meta-analyses, are presented as a function of the type of d index. 
Descriptive analyses of these distributions are shown for the meta-analyses using the 
posttest standardized mean difference (see Table 1), the standardized mean change (see 
Table 2) and the standardized mean change difference (see Table 3). Figure 1 shows the 
corresponding box plots of the analysed distributions, for the meta-analyses using the 
posttest standardized mean differences (d) and the standardized mean changes (dc), and 
Figure 2 presents histograms of mean effect sizes and between-studies variances 
distributions for the meta-analyses using the posttest standardized mean differences (d) 
and the standardized mean changes (dc). Only two meta-analyses used the standardized 
mean change difference. 
     
INSERT TABLE 1 AND FIGURES 1 AND 2 
 
Number of studies  
 
 In the 41 meta-analyses with the posttest standardized mean difference as the 
effect size index, the number of primary studies ranged from k = 7, the minimum 
number of studies for a meta-analysis to be included in this review, to k = 70. The first 
quartile, median, mean, and third quartile were 14, 18, 24.2, and 25 studies, respectively 
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(see Table 1). These results reflected a clear positive skewness, or the predominance of 
meta-analyses with a small number of studies. Furthermore, as can be seen in Figure 1, 
there were four outliers, namely 45, 54, 61, and 70 studies, resulting in the mean, 24.2, 
being larger than the median, 18.  
 
INSERT TABLE 2 
 
 The distribution of the number of studies in the standardized mean change meta-
analyses was more variable and more skewed than that of the posttest standardized 
mean difference meta-analyses (see Figure 1). The first quartile, median, mean, and 
third quartile were 10, 13, 24.09, and 30 studies, respectively (see Table 2). These 
results evidenced a more pronounced positive skewness than in the case of the posttest 
standardized mean difference meta-analyses. Once again, most meta-analyses included 
a small number of studies. The number of studies for the two meta-analyses using the 
standardized mean change difference were 9 and 19, respectively (see Table 3).   
 
INSERT TABLE 3 
   
Effect sizes distribution 
 
 The mean effect size, the p-value of the Shapiro-Wilk test for normality, the 
skewness and kurtosis of the effect sizes were computed for each meta-analysis. To 
analyse the distribution of the mean effect sizes, these means were taken in absolute 
value. Note that the sign of a d index is arbitrary, as it depends on the order in which the 
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means of the two groups in each primary study are subtracted. Then, our interest was on 
the magnitude of the mean effect sizes. 
 
 In the posttest standardized mean difference meta-analyses, the first quartile, 
median, mean, and third quartile of the mean effect sizes distribution, were 0.249, 
0.409, 0.472, and 0.695, respectively (see Table 1). These results are similar to the three 
values, 0.2, 0.5, and 0.8, reflecting a low, medium, and high magnitude, respectively, 
according to Cohen (1988).    
 
 The shape of the distribution of the posttest standardized mean differences in 
each meta-analysis was also examined. The Shapiro-Wilk test for normality was 
statistically significant in 39.02% of the meta-analyses, being .211 the mean of the       
p-values associated to this normality test. The skewness of distributions ranged from      
-1.947 to 2.354, being 0.179 the first quartile. Kurtosis ranged from -1.758 to 6.001 (see 
Table 1). This means that the effect size distribution was positively skewed in most 
meta-analyses, with a statistically significant departure from normality in almost 40% of 
the meta-analyses.   
 
 In the meta-analyses using the standardized mean change, the three quartiles, the 
mean, and the maximum values in the mean effect sizes distribution were larger than 
those in the standardized mean difference meta-analyses (see Table 2 and Figures 1 and 
2). Specifically, the three quartiles were 0.640, 0.747, and 1.258, the mean was 0.976, 
and the maximum 2.219, which was treated as an outlier. Note that these results 
remarkably exceed the 0.2, 0.5, and 0.8 values proposed by Cohen (1988).      
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 Similar to posttest standardized mean differences, the shape of the standardized 
mean change distributions deviated from the normality assumption. This deviation was 
statistically significant in 36.36% of the meta-analyses, according to the Shapiro-Wilk 
test. The skewness and kurtosis distributions ranged from negative values in the first 
quartile to positive ones in the third quartile (see Table 2).  
 
 In the two meta-analyses using the standardized mean change difference, the 
mean effect sizes were 1.307 and 0.629, respectively (see Table 3). The skewness and 
kurtosis values were 0.383 and -1.358 for the first meta-analysis, and -0.514 and -1.076 
for the second meta-analysis. However, in both meta-analyses, the Shapiro-Wilk test 
was not statistically significant, the p-values being .173 and .108, respectively.  
 
Sample size distribution 
 
 We examined the sample size distribution through the k primary studies in each 
meta-analysis, by computing the median sample size, the skewness and kurtosis of the 
sample sizes. The distribution of these statistics was analyzed through the 41, 11, and 2 
meta-analyses with different d effect size indices.   
 
 In the posttest standardized mean difference meta-analyses, the median sample 
size ranged from 16 to 87.5, the mean being 48.6 (see Table 1). The first quartile of the 
skewness values was 0.914, which reflects a positive skewness of the sample size 
distributions in most meta-analyses (e.g., there was a predominance of primary studies 
with small sample sizes). The kurtosis values showed a large dispersion, ranging from   
-1.512 to 14.170, the first and third quartiles being -0.477 and 2.684, respectively. 
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 The sample sizes in the primary studies of the standardized mean change meta-
analyses were lower than those in the posttest standardized mean difference meta-
analyses (see Table 2 and Figure 1). The median sample size ranged from 9 to 74 (an 
outlier), with a positively skewed distribution, where the three quartiles and the mean 
(16, 19.5, 37.5, and 30.86, respectively) were remarkably lower than those in the meta-
analyses using the posttest standardized mean difference (32, 46.5, 64, and 48.6, 
respectively). The skewness values of the sample size distributions were all positive, 
ranging from 0.153 to 2.234, and again suggesting the predominance of small sample 
sizes. The kurtosis values, ranging from -1.859 to 6.149, once again showed a large 
variability. 
   
 In the two standardized mean change difference meta-analyses, the median of 
the sample sizes were 28 and 38, respectively (see Table 3).  The skewness of the 
sample sizes was similar in the two meta-analyses, whereas kurtosis values showed a 
higher discrepancy. 
  
Correlation between effect sizes and sample sizes 
 
 Regarding meta-analyses using the posttest standardized mean difference, the 
correlations between effect sizes and sample sizes ranged from -.612 to .734. Most 
correlations (70.73%) were negative, being -.119 the mean value (see Table 1). Out of 
the total of correlations, 14.63% were statistically significant (3 positive and 3 
negative).  
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 A wide range of correlations, from -.736 to .622, was also found in the 
standardized mean change meta-analyses (see Table 2 and Figure 1). However, in this 
case most correlations (72.73%) were positive and the mean of the correlations was also 
positive (.060).  Out of the total of correlations, 27.27% were statistically significant (2 
positive and 1 negative).  
 
 As shown in Table 3, in the first meta-analysis the correlation between the 
standardized mean change differences and sample sizes was positive and not 
statistically significant (r = .258). On the contrary, in the other meta-analysis the 
correlation was negative and statistically significant (r = -.496).  
 
Heterogeneity 
 
 Three meta-analytic indices were used in order to study the heterogeneity of the 
effect sizes in the included meta-analyses: the Q statistic (Equation 17), the I2 index 
(Equation 21), and the between-studies variance, 2ˆ , estimated through the DL, REML 
and PM procedures (Equations 16, 19 and 20, respectively). As the results of the three 
estimators of the between-studies variance were very similar, we will only describe the 
findings relative to DL estimator, 2ˆDL  .   
 
 In the meta-analyses using the posttest standardized mean difference, the third 
quartile of the distribution of p values associated to the Q statistics was .035, below the 
.05 significance level (see Table 1). In particular, 75.6 % of the Q tests were statistically 
significant at the .05 level (see Appendix 1).  
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 As also shown in Table 1, the three quartiles of the I2 distribution were 37.71%, 
59.86%, and 74.83%. These results are relatively close to the three values, 25%, 50%, 
and 75% proposed by Higgins and Thompson (2002) as reflecting low, medium and 
high heterogeneity, respectively. Furthermore, 87.80% of the I2 values were above 25%, 
that is to say, 36 out of the 41 meta-analyses showed a medium or high variability in the 
effect sizes (see Appendix 1).  
 
In the same vein, the three quartiles of the 2ˆ
DL  values were  0.055, 0.111, and 0.171, 
respectively, with four outliers in the distribution, namely 1.025, 0.433, 0.522, and 
0.384 (see Figures 1 and 2).  
 
 The heterogeneity Q test was statistically significant in all the standardized mean 
change meta-analyses (see Table 2). The I2 values ranged from 44.99% to 93.46%, and 
the 2ˆ
DL  ones ranged from 0.056 to 0.512. Then, all the meta-analyses exhibited a 
medium to large heterogeneity. As shown in Figure 1, the I2 and 2ˆ
DL  values were 
generally larger in these meta-analyses, as compared to the posttest standardized mean 
difference meta-analyses.      
 
 The two meta-analyses using the standardized mean change difference showed a 
statistically significant heterogeneity, with large I2 and 2ˆ
DL  values, above 68% and 0.10, 
respectively (see Table 3).      
 
4. Discussion 
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 The aim of this paper was to analyse the methodological characteristics of 54 
meta-analyses about the effectiveness of psychological treatments in the Clinical 
Psychology area, with the standardized mean difference as the effect size index. These 
meta-analyses were extracted from the most high-impact journals in the field of clinical 
psychology, located in the first quartile of the ranking of the Journal Citation Reports.  
 
 The typical design in the primary studies evaluating the effectiveness of an 
intervention program was the pretest-postest-control group design. Most meta-analyses, 
41 out of 54, used the standardized mean difference computed from the posttest scores 
to compare experimental and control groups (Equation 1). Eleven meta-analyses used 
the standardized mean change from pretest to posttest only in the treated groups 
(Equations 4 and 6), usually because some of the primary studies compared different 
treatments without including control groups. Finally, only two meta-analyses (Aderka et 
al. 2012 and Virués-Ortega, 2010b) used the standardized mean change difference 
proposed by Morris (2008) (Equation 12), where the gains from pretest to posttest are 
compared between the experimental and control groups. 
 
 The classic standardized mean difference computed from the posttest scores 
does not take into account the usual pre-differences between treatment and control 
groups, which also can occur in randomized studies. This poses a threat to the internal 
validity of the results. The standardized mean change from pretest to posttest in a 
treatment group can be affected by maturation, history or testing effects, which also 
represent a threat to the internal validity (Shadish, Cook, & Campbell, 2002). These 
limitations in both indices are partly overcome by using the standardized mean change 
difference between the experimental and control groups (Morris, 2008). Then, although 
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in practice the standardized mean change difference is scarcely used (only in two out of 
our 54 meta-analyses), it should be considered in future meta-analyses.  
 
 The standardized mean change difference gives very similar results to those of 
the standardized mean difference computed from the change scores from pretest to 
posttest. This is especially true when the pretest scores are similar in the experimental 
and control groups. As a consequence, the methodological characteristics of our 41 
meta-analyses using the posttest standardized mean difference, can also serve to guide 
the design of the future research about the meta-analyses using the standardized mean 
change difference, as well as the correct interpretation of these meta-analyses.  
 
 In the global analysis of the 54 meta-analyses, many of them presented a 
relatively low number of studies (below 20) and a substantial heterogeneity in the effect 
sizes, with I2 values generally larger than 50%, and 2ˆ  values larger than 0.10. Thus, the 
performance of the meta-analytic statistical methods under these conditions should be a 
research topic of interest. It is widely known that the Q statistic for heterogeneity is 
underpowered in meta-analyses with a low number of studies (Sánchez-Meca & Marín-
Martínez, 1997). However, in our review, 44 out of the 54 meta-analyses showed a 
statistically significant heterogeneity in the effect sizes (p < .05). This is because of the 
large I2 and 2ˆ values found in most meta-analyses, with only two meta-analyses 
showing an I2 = 0% and 2ˆ = 0. These findings are in line with other studies supporting 
the random-effects model as a more realistic option than the fixed-effect model, on the 
basis that there is substantial variability in the effect sizes of a meta-analysis (Hedges & 
Vevea, 1998; National Research Council, 1992; Raudenbush, 1994, 2009).  
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 Cohen (1988) proposed a guide to interpret the magnitude of the standardized 
mean difference in the Social Sciences, where values around 0.2, 0.5, and 0.8, represent 
a low, medium and high magnitude, respectively. This guide should be adapted to the 
specific field of study, taking into account the typical distribution of effect sizes in the 
corresponding context (Ferguson, 2009; Hill, Bloom, Black, & Lipsey, 2008; Valentine 
& Cooper, 2003). In this vein, our study contributes to provide a tentative classification 
of the effect size magnitude of clinical psychology treatments, through the analysis of 
the distribution of mean effect sizes from our meta-analyses. Correct interpretation of 
the effect sizes in the empirical research makes it possible to determine the 
practical/clinical significance of the results, as a complement of the statistical 
significance (Kirk, 1996). Furthermore, the researcher can decide on the minimum 
effect size of interest to a priori determine the sample size of an empirical study, with 
the desired statistical power (Cohen, 1988).  
 
 The three quartiles of the mean effect size distribution were 0.249, 0.409, and 
0.695, for the meta-analyses using the standardized mean difference computed from the 
posttest scores. These values, similar to those in Cohen (1988), could be interpreted as a 
low, medium, and high magnitude, respectively, in the clinical psychology context. To 
be more specific, for example, a value of  d = 0.80 could be interpreted as a high 
magnitude above the percentile 75 in the distribution of average effect sizes in the 
clinical psychology area. An important point is that this classification can only be 
applied to the posttest standardized mean differences, and the standardized mean change 
differences, but not to the standardized mean changes from pretest to posttest.         
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 Meta-analyses using the standardized mean change as an effect size index are 
more common than researchers would expect to find. This is because of the absence of 
control groups in the empirical research for ethical reasons, or when the studies are 
confined to compare different active treatments without including a control group. In 
general terms, the values of the standardized mean change are larger than those of the 
posttest standardized mean difference. According to our review, the three quartiles 0.64, 
0.747, and 1.258 could be interpreted as a low, medium, and high magnitude. This 
classification should be used instead of Cohen’s proposal, for the interpretation of the 
standardized mean change values in the clinical psychological context.  
 
 The distribution of the effect sizes in the reviewed meta-analyses deviated from 
the normality assumption in the random-effects model. The skewness and kurtosis 
values ranged from negative to positive values of a remarkable magnitude, and the 
Shapiro-Wilk test for normality was statistically significant in almost 40% of the meta-
analyses, in spite of the low number of studies in most of them, which reduces the 
statistical power of the test. These findings suggest the need to examine the robustness 
of the meta-analytic procedures to the violation of the normality assumption in the 
distribution of the effect sizes (see, for example, Kontopantelis & Reeves, 2012), as 
well as the development of new robust meta-analytic procedures.    
 
 The Pearson correlation between effect sizes and sample sizes was statistically 
significant in 10 out of the 54 meta-analyses, with 5 positive correlations and 5 
negative. Once again, the low number of studies in numerous meta-analyses reduces the 
statistical power of the t-test for the significance of a correlation, thus preventing the 
recognition of part of the true correlations. The distribution of the Pearson correlations 
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in the meta-analyses, with values of a remarkable magnitude, could reflect publication 
selection bias or possibly some other moderator confounded with sample size (e.g., 
implementation quality) (Levine et al., 2009).  As a consequence, the research about the 
performance of the meta-analytic procedures should consider scenarios with positive 
and negative correlation values between effect sizes and sample sizes, similar to those 
found in our study.            
 The present review of meta-analyses provides the minimum, maximum, the 
mean, and three quartiles of the distribution of the different components in a meta-
analysis: number of studies; mean effect size; skewness and kurtosis of the effect size 
distribution; median, skewness and kurtosis of the sample size distribution; Pearson 
correlation between effect sizes and sample sizes; and I2 and 2ˆ heterogeneity indices 
(see Tables 1-3). These specific values are representative of the realistic conditions in a 
meta-analysis, which should be contemplated in the research about the performance of 
the meta-analytic procedures (see the next section of recommendations).  
 
Limitations of the study 
 
A requirement of the current review was to include only meta-analyses that 
reported individual effect sizes and sample sizes for the primary studies. That inclusion 
criterion might lead to exclusion of meta-analyses with a large number of studies, due to 
journal space limitations. Nonetheless, our review included meta-analyses with a 
number of studies ranging from 7 to 70, which can be regarded as a wide range that 
realistically covers the size of most meta-analyses conducted in social and behavioural 
sciences.  
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Only two meta-analyses out of the 54 in the review used the standardized mean 
change difference (Equation 12), where the change scores from pretest to posttest 
between the experimental and control groups were compared. This index, although 
scarcely used in practice, overcomes some important limitations of the posttest 
standardized mean difference and the standardized mean change. As a consequence, it is 
suggested that future reviews include a larger number of meta-analyses using the 
standardized mean change difference.  
 
This review is limited to meta-analyses about the effectiveness of clinical 
psychology treatments, using standardized mean differences as the effect index. Future 
reviews of meta-analyses in other research areas and with other effect size indices will 
shed light on the realistic meta-analytic conditions and the typical distribution of the 
effect sizes in those disciplines. 
 
Recommendations overview   
 
Several recommendations can be made for researchers carrying out a meta-
analysis, a Monte Carlo or theoretical study about meta-analytic methods, or a primary 
study. For studies with a pretest-posttest control group design, the best option is to 
compute the standardized mean change difference in each study with Equation 12. This 
index, although scarcely used in practice, has the advantage of controlling for pretest 
differences between groups, as well as maturation, history or testing effects from pretest 
to posttest. Our paper presents three indices of the standardized mean change difference: 
dg1, dg2, and dg3, (Equations 8, 10, and 12, respectively), and the latter has been found to 
outperform the other indices in terms of bias, precision and robustness to heterogeneity 
of variance (Morris, 2008).           
32 
 
 
The posttest standardized mean difference, d (Equation 1), while widely applied 
in numerous meta-analyses, does not control for baseline differences between groups, 
which can also occur in randomized studies. However, in meta-analyses including 
studies with and without pretest, the d index is the best option for all studies. This is 
because different standardized mean differences (e.g. posttest standardized mean 
differences, standardized mean changes from pretest to posttest, or standardized mean 
change differences) should not be combined in the same meta-analysis, since they are 
not directly comparable.       
 
For studies with a pretest-posttest design without a control group, the usual 
approach is to compute a standardized mean change from pretest to posttest (dc1 and dc2 
indices in Equations 4 and 6, respectively). These indices may be affected by 
maturation, history or testing effects. However, in meta-analyses where a sizeable 
number of studies do not include a control group, due to ethical reasons or that only 
active treatments are compared, the dc index could be computed in all studies. In this 
paper we present two types of dc indices which differ in the estimator of the standard 
deviation in the denominator of their formulas. The dc1 index (Equation 4) uses the 
standard deviation of the change scores from pretest to posttest, while dc2 index 
(Equation 6) uses the standard deviation of the pretest scores. Most primary studies 
report the standard deviations of the pretest and posttest scores, whereas the standard 
deviation of the change scores is less frequently reported. Therefore, the computation of 
dc2 index - based on the standard deviation of the pretest scores - will be more feasible 
in practice, and will provide an estimation of the effect size more similar to those in the 
inter-group designs.    
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Monte Carlo and theoretical studies with a scope on meta-analytic methods 
should consider scenarios found in real meta-analyses. Results in Tables 1-3 of this 
paper can inform the design of methodological studies in this context. For example, in a 
Monte Carlo study simulating data from meta-analyses using the posttest standardized 
mean difference or the standardized mean change difference, the number of studies, the 
sample size distribution in the primary studies, or the variance in the effect size 
distribution could be manipulated using the values in Table 1. For the number of 
studies, k, five values could be considered: 7, 14, 18, 25, and 70 (minimum, three 
quartiles, and maximum). Similarly, the sample size distribution could be manipulated 
with average values 16, 32, 46, 64, and 87 (minimum, three quartiles, and maximum), 
skewness of 1.357 (median), and kurtosis of .722 (median). Last, the variance of the 
effect size distribution, 2ˆ , could be set to values of 0, 0.055, 0.111, 0.171, and 1.024 
(minimum, three quartiles, and maximum). These results may also be useful in a 
Bayesian framework, as they can inspire the construction of an empirical prior.  
 
The distribution of average effect sizes throughout the reviewed meta-analyses 
can help to assess the practical significance (e.g. clinical significance) of an effect size 
in a primary empirical study or a meta-analysis in this context. For example, a value of 
d = 0.20 for the posttest standardized mean difference could be interpreted as a low 
magnitude below the 25th percentile (0.249) in the distribution of the average effect 
sizes in clinical Psychology (see Table 1). Furthermore, the benchmarks (minimum, 
quartiles 1-3, and maximum) can help the researcher decide on the minimum effect size 
to a priori determine the sample size of an empirical study, with the desired statistical 
power.  
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5. Conclusions 
 
 The results of this review of meta-analyses allow the proper interpretation of the 
magnitude of the different types of standardized mean differences in the specific area of 
the evaluation of the effectiveness of the clinical psychological treatments. This is 
valuable information to interpret the clinical significance of the results in both a primary 
research study and a meta-analysis, through the effect sizes in the individual studies, 
and the average effect size, overall and by subgroups of studies, in a meta-analysis. 
 
 Future research on the performance of the meta-analytic procedures should take 
into account the methodological characteristics of the real meta-analysis in the different 
areas of research. Particularly, in this work we have analysed the number of studies, the 
sample size distribution in the studies, the effect size distribution, and the Pearson 
correlation between effect sizes and sample sizes of 54 real meta-analysis in the clinical 
psychology area. In this vein, Monte Carlo and theoretical studies could use the values 
reported in our study to simulate realistic scenarios.  
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Table 1. Descriptive analyses of the meta-analytic calculations for posttest standardized 
mean difference.  
 
 
 
 
 
 
 
 
 
 
 
 Min. 1st Qu. Median Mean 3rd Qu. Max. 
k 7 14 18 24.2 25 70 
 .068 .249 .409 .472 .695 1.075 
p_norm .000 .008 .138 .211 .312 .858 
d_skewness -1.947 .179 .571 .503 .994 2.354 
d_kurtosis -1.758 -.839 -.212 .414 1.033 6.001 
N_median 16 32 46.5 48.6 64 87.5 
N_skewness -1.085 .914 1.357 1.350 1.762 3.487 
N_kurtosis -1.512 -.477 .722 1.749 2.684 14.170 
 -.612 -.329 -.212 -.119 .059 .734 
p_Q .000 .000 .000 .095 .035 .981 
I2 0 37.71 59.86 54 74.83 93.61 
2ˆ
DL  .000 .055 .111 .159 .171 1.024 
2ˆ
REML  .000 .043 .108 .181 .179 .816 
2ˆ
PM  .000 .059 .129 .215 .352 .789 
Note. Min. = minimum; 1st Qu. = First Quartile; 3rd Qu. = Third Quartile; Max. = maximum; 
k = number of studies; = average effect sizes applying DL to estimate the between-studies variance; 
p_norm = p-value associated to the Shapiro-Wilk test; d_skewness = skewness of effect sizes; 
d_kurtosis = kurtosis of effect sizes; N_median = median of sample sizes ; N_skewness = skewness of 
sample sizes; N_kurtosis = kurtosis of sample sizes;  = correlation between effect sizes and sample 
sizes; p_Q = p-value associated to the heterogeneity Q statistic; I2 = index to quantify the amount of 
heterogeneity (in %); 
2ˆ
DL = between-studies variance estimated through the DerSimonian and Laird; 
2ˆ
REML  = between-studies variance estimated through restricted maximum likelihood; 
2ˆ
PM = between-
studies variance estimated through Paule and Mandel.  
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Table 2. Descriptive analyses of the meta-analytic calculations for standardized mean 
change 
 
 
 
 
 
 
 
 
 
 
 Min. 1st Qu. Median Mean 3rd Qu. Max. 
k 8 10 13 24.09 30 70 
 
.038 .640 .747 .976 1.258 2.219 
p_norm .000 .001 .334 .320 .586 .830 
d_skewness -1.179 -.114 .562 .476 .951 2.347 
d_kurtosis -1.418 -.869 -.483 .755 1.009 8.559 
N_median 9 16 19.5 30.86 37.5 74 
N_skewness .153 .683 1.284 1.208 1.695 2.234 
N_kurtosis -1.859 -1.055 -1.088 1.078 2.265 6.149 
 -.736 -.054 .045 .060 .318 .622 
p_Q .000 .000 .000 .002 .000 .013 
I2 44.99 64.86 72.67 72.74 81.61 93.46 
2ˆ
DL  .056 .099 .124 .185 .163 .512 
2ˆ
REML  .064 .105 .136 .211 .219 .588 
2ˆ
PM  .062 .088 .161 .299 .341 .588 
Note. Min. = minimum; 1st Qu. = First Quartile; 3rd Qu. = Third Quartile; Max. = maximum; 
k = number of studies; = average effect sizes applying DL to estimate the between-studies 
variance; p_norm = p-value associated to the Shapiro-Wilk test; d_skewness = skewness of effect 
sizes; d_kurtosis = kurtosis of effect sizes; N_median = median of sample sizes ; N_skewness = 
skewness of sample sizes; N_kurtosis = kurtosis of sample sizes;  = correlation between effect 
sizes and sample sizes; p_Q = p-value associated to the heterogeneity Q statistic; I2 = index to quantify 
the amount of heterogeneity (in %); 
2ˆ
DL = between-studies variance estimated through the 
DerSimonian and Laird; 
2ˆ
REML  = between-studies variance estimated through restricted maximum 
likelihood; 
2ˆ
PM = between-studies variance estimated through Paule and Mandel.  
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Table 3. Meta-analytic calculations for standardized mean change difference 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 Meta-analysis 1 Meta-analysis 2 
k 9 19 
 1.307 .629 
p_norm .173 .108 
d_skewness .383 -.514 
d_kurtosis -1.358 -1.076 
N_median 28 38 
N_skewness 1.026 1.745 
N_kurtosis .006 2.296 
 .258 -.496 
p_Q .001 .000 
I2 69.49 68.45 
2ˆ
DL  .242 .109 
2ˆ
REML  .213 .083 
2ˆ
PM  .190 .066 
Note. k = number of studies; = average effect size applying DL to estimate the between-studies 
variance; p_norm = p-value associated to the Shapiro-Wilk test; d_skewness = skewness of effect 
sizes; d_kurtosis = kurtosis of effect sizes; N_median = median of sample sizes ; N_skewness = 
skewness of sample sizes; N_kurtosis = kurtosis of sample sizes;  = correlation between effect 
sizes and sample sizes; p_Q = p-value associated to the heterogeneity Q statistic; I2 = index to quantify 
the amount of heterogeneity (in %); 
2ˆ
DL = between-studies variance estimated through the 
DerSimonian and Laird; 
2ˆ
REML  = between-studies variance estimated through restricted maximum 
likelihood; 
2ˆ
PM = between-studies variance estimated through Paule and Mandel.  
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Figure 1.  Boxplots of some meta-analytic indices 
 
Note. d = Posttest Standardized Mean Difference; dc = Standardized Mean Change; the 
between-studies variance was estimated through the DerSimonian and Laird procedure.  
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Figure 2.  Histograms of the distribution of mean effect sizes and between-studies 
variances for posttest standardized mean difference (d) and standardized mean change 
(dc) 
 
Note. The between-studies variance was estimated through the DerSimonian and Laird 
procedure.  
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Appendix 1 - Characteristics of the meta-analyses included in the systematic review 
 
Meta-analysis d index 
(Equation) 
Formula for the 
sampling variance 
k 
 
 
2ˆ
DL  
2ˆ
REML  
2ˆ
PM  p  I
2 
Abramowitz et al.  (2001) d (1) Equ. 3 54  .250 .522 .625 .719 < .0001 81.3 
Acarturk et al. (2009) d (1) Equ. 3 45 .740 .111 .104 .088 .0001 50.3 
Aderka et al. (2012) dg3 (12) Equ. 13 19 .630 .109 .083 .066 < .0001 68.5 
Bell & D'Zurilla (2009) d (1) Equ. 3 21 .694 .391 .560 .567 < .0001 83.6 
Benish et al.  (2008) d (1) Equ. 3 15 .187 .000 .000 .000 .9808 0 
Burke et al. (2003) d (1) Equ. 3 13 .291 .022 .019 .020 .0824 37.7 
Casement & Swanson (2012) dc2 (6) Equ. 7 13 .696 .090 .070 .062 < .0001 77.9 
Cuijpers et al. (2009) d (1) Equ. 3 19 .307 .002 .012 .001 .4098 3.8 
Cuijpers et al. (2010) d (1) Equ. 3 70 .195 .058 .056 .070 .0021 35.8 
Cuijpers et al. (2010) d (1) Equ. 3 24 .067 .098 .101 .099 .0093 45.1 
Cuijpers et al.  (2011) d (1) Equ. 3 15 .289 .000 .000 .000 .8662 0 
Cuijpers et al. (2012) d (1) Equ. 3 18 .589 .008 .007 .008 .3501 8.8 
Dixon et al. (2007) d (1) Equ. 3 20 .205 .008 .000 .014 .2493 16.4 
Driessen et al. (2010) dc2 (6) Equ. 7 21 1.266 .152 .177 .173 < .0001 72.7 
Ekers et al.  (2008) d (1) Equ. 3 14 .072 .051 .038 .061 .1607 27.4 
Gooding & Tarrier (2009) d (1) Equ. 3 18 .726 .163 .179 .164 < .0001 67.8 
Hanrahan et al. (2012) d (1) Equ. 3 19 .928 .433 .689 .789 < .0001 81.8 
Hansen et al. (2012) dc2 (6) Equ. 7 11 .563 .084 .106 .103 < .0001 83.1 
Harris (2006) d (1) Equ. 3 14 .240 .081 .092 .109 .0004 65.3 
Haug et al. (2012) d (1) Equ. 3 54 .799 .132 .130 .123 < .0001 71.8 
Hausenblas et al. (2012) dc1 (4) Equ. 5 54 .038 .056 .064 .069 < .0001 62.9 
Hesser et al. (2011)a d (1) Equ. 3 25 .600 .046 .043 .047 .0123 43.1 
Hesser et al. (2011)b dc2 (6) Equ. 7 10 .584 .100 .104 .102 < .0001 90.2 
Kalu et al. (2012) d (1) Equ. 3 7 .738 .272 .311 .389 .0266 58.0 
Kleinstäuber et al. (2011) d (1) Equ. 3 18 .399 .142 .169 .192 < .0001 75.1 
Lackner et al. (2004) d (1) Equ. 3 12 .766 .106 .109 .165 .0354 47.1 
Lansbergen et al.  (2007) d (1) Equ. 3 18 .220 .384 .636 .685 < .0001 86.1 
Lissek et al. (2005) d (1) Equ. 3 22 .219 .130 .140 .162 .0002 59.9 
Lundahl et al. (2006) d (1) Equ. 3 70 .463 .055 .058 .046 .0004 39.9 
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Malouff et al.  (2007) d (1) Equ. 3 38 .546 .292 .538 .680 < .0001 83.6 
Malouff et al. (2008) d (1) Equ. 3 15 .476 .125 .150 .163 < .0001 74.8 
Nestoriuc et al. (2008)a d (1) Equ. 3 18 .298 .018 .015 .021 .2970 13.1 
Nestoriuc et al. (2008)b dc1 (4) Equ. 5 70 .747 .124 .112 .161 < .0001 44.9 
Oldham et al. (2012) d (1) Equ. 3 33 .378 .062 .065 .066 < .0001 65.0 
Opris et al. (2012) d (1) Equ. 3 23 .490 .255 .294 .352 < .0001 67.4 
Pérez-Mañá et al. (2011) d (1) Equ. 3 21 .203 .081 .071 .059 < .0001 63.4 
Prendergast et al.  (2001) d (1) Equ. 3 11 .393 .157 .108 .083 < .0001 75.0 
Richards& Richardson (2012) d (1) Equ. 3 33 .565 .141 .139 .129 < .0001 81.1 
Roberts et al. (2007) d (1) Equ. 3 14 .363 .023 .011 .027 .1971 23.8 
Rodenburg et al. (2009) d (1) Equ. 3 7 .560 .065 .068 .064 .1831 32.1 
Rosa-Alcázar et al (2008) d (1) Equ. 3 24 1.075 .173 .172 .378 .0002 57.9 
Sánchez-Meca et al. (2010) d (1) Equ. 3 61 1.012 .261 .317 .363 < .0001 71.0 
Shadish & Baldwin (2005) d (1) Equ. 3 30 .708 .160 .035 .431 .0014 49.3 
Smit et al. (2012) d (1) Equ. 3 10 .331 1.024 .816 .789 < .0001 93.6 
Sockoll et al.  (2011)a d (1) Equ. 3 14 .764 .171 .189 .194 < .0001 70.4 
Sockoll et al.  (2011)b dc1 (4) Equ. 5 24 1.662 .467 .521 .510 < .0001 80.1 
Spek et al. (2007) d (1) Equ. 3 11 .409 .077 .134 .145 < .0001 78.6 
Sprenger et al. (2011) d (1) Equ. 3 10 .627 .114 .114 .147 .0174 55.2 
Virués-Ortega (2010)a dc2 (6) Equ. 7 8 .984 .159 .179 .294 .0037 66.8 
Virués-Ortega (2010)b dg3 (12) Equ. 13 9 1.307 .242 .213 .190 .0010 69.5 
Western & Morrison (2001) dc2 (6) Equ. 7 8 2.220 .512 .588 .589 < .0001 93.5 
Williams et al. (2006) dc2 (6) Equ. 7 10 1.250 .117 .136 .073 .0131 56.9 
Wittouck et al. (2011) d (1) Equ. 3 14 .163 .095 .105 .190 .0005 64.3 
Young et al. (2007) dc2 (6) Equ. 7 36 .725 .167 .261 .387 < .0001 71.0 
          
Note. d = posttest standardized mean difference; dc1 = standardized mean change calculated using in the denominator the standard deviation of the pretest-
posttest change scores; dc2 = standardized mean change calculated using in the denominator the standard deviation of the pretest scores; dg3 = standardized 
mean change difference calculated using in the denominator an average of the pretest standard deviations in the experimental and control groups; k = number 
of studies;  = mean effect size applying DL to estimate the between-studies variance;  
2ˆ
DL = between-studies variance estimated through the DerSimonian 
and Laird; 
2ˆ
REML  = between-studies variance estimated through restricted maximum likelihood; 
2ˆ
PM = between-studies variance estimated through Paule and 
Mandel; p = p-value associated to the heterogeneity Q statistic; I2 = index to quantify the amount of heterogeneity (%). 
